Radiotherapy & Oncology
Volume 94, Issue 2 , Pages 168-172 , February 2010

The use of probability maps to deal with the uncertainties in prostate cancer delineation

Received 19 October 2009 ,Revised 9 December 2009 ,Accepted 20 December 2009.

References 

  1. Buckley DL, Roberts C, Parker GJM, Logue JP, Hutchinson CE. Prostate cancer: evaluation of vascular characteristics with dynamic contrast-enhanced T1-weighted MR imaging – initial experience. Radiology. 2004;233:709–715
  2. Franiel T, Lüdemann L, Rudolph B, et al. Evaluation of normal prostate tissue, chronic prostatitis, and prostate cancer by quantitative perfusion analysis using a dynamic contrast-enhanced inversion-prepared dual-contrast gradient echo sequence. Invest Radiol. 2008;43:481–487
  3. Kozlowski P, Chang SD, Jones EC, Berean KW, Chen H, Goldenberg SL. Combined diffusion-weighted and dynamic contrast-enhanced MRI for prostate cancer diagnosis – correlation with biopsy and histopathology. J Magn Reson Imaging. 2006;24:108–113
  4. van Dorsten FA, van der Graaf M, Engelbrecht MRW, et al. Combined quantitative dynamic contrast-enhanced MR imaging and (1)H MR spectroscopic imaging of human prostate cancer. J Magn Reson Imaging. 2004;20:279–287
  5. Ocak I, Bernardo M, Metzger G, et al. Dynamic contrast-enhanced MRI of prostate cancer at 3T: a study of pharmacokinetic parameters. AJR Am J Roentgenol. 2007;189:849
  6. Hara N, Okuizumi M, Kawaguchi M, Bilim V. Dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) is a useful modality for the precise detection and staging of early prostate cancer. Prostate. 2005;62:140–147
  7. Fütterer JJ, Heijmink SWTPJ, Scheenen TWJ, et al. Prostate cancer localization with dynamic contrast-enhanced MR imaging and proton MR spectroscopic imaging. Radiology. 2006;241:449–458
  8. Ito H, Kamoi K, Yokoyama K, Yamada K, Nishimura T. Visualization of prostate cancer using dynamic contrast-enhanced MRI: comparison with transrectal power Doppler ultrasound. Br J Radiol. 2003;76:617–624
  9. Kim C, Park B, Kim B. Localization of prostate cancer using 3T MRI: comparison of T2-weighted and dynamic contrast-enhanced imaging. J Comput Assist Tomogr. 2006;30:7–11
  10. van Vulpen M, van den Berg C, Moman M, van der Heide U. Difficulties and potential of correlating local recurrences in prostate cancer with the delivered local dose. Radiother Oncol. 2009;93:180–184
  11. Franiel T, Lüdemann L, Taupitz M, Böhmer D, Beyersdorff D. MRI before and after external beam intensity-modulated radiotherapy of patients with prostate cancer: the feasibility of monitoring of radiation-induced tissue changes using a dynamic contrast-enhanced inversion-prepared dual-contrast gradient echo sequence. Radiother Oncol. 2009;93:241–245
  12. Kershaw L, Logue J, Hutchinson C, Clarke N, Buckley D. Late tissue effects following radiotherapy and neoadjuvant hormone therapy of the prostate measured with quantitative magnetic resonance imaging. Radiother Oncol. 2008;88:127–134
  13. Pickett B, Vigneault E, Kurhanewicz J, Verhey L, Roach M. Static field intensity modulation to treat a dominant intra-prostatic lesion to 90Gy compared to seven field 3-dimensional radiotherapy. Int J Radiat Oncol Biol Phys. 1999;44:921–929
  14. Nederveen AJ, Van der Heide UA, Hofman P, Welleweerd H, Lagendijk JJ. Partial boosting of prostate tumours. Radiother Oncol. 2001;61:117–126
  15. Meerleer GD, Villeirs G, Bral S, et al. The magnetic resonance detected intraprostatic lesion in prostate cancer: planning and delivery of intensity-modulated radiotherapy. Radiother Oncol. 2005;75:325–333
  16. van Lin ENJT, Fütterer JJ, Heijmink SWTPJ, et al. IMRT boost dose planning on dominant intraprostatic lesions: gold marker-based three-dimensional fusion of CT with dynamic contrast-enhanced and 1H-spectroscopic MRI. Int J Radiat Oncol Biol Phys. 2006;65:291–303
  17. Henderson E, Milosevic MF, Haider MA, Yeung IWT. Functional CT imaging of prostate cancer. Phys Med Biol. 2003;48:3085–3100
  18. Jeukens CRLPN, Van den Berg CAT, Donker R, et al. Feasibility and measurement precision of 3D quantitative blood flow mapping of the prostate using dynamic contrast-enhanced multi-slice CT. Phys Med Biol. 2006;51:4329–4343
  19. Harvey C, Blomley M, Dawson P, et al. Functional CT imaging of the acute hyperemic response to radiation therapy of the prostate gland: early experience. J Comput Assist Tomogr. 2001;25:43–49
  20. Win Z, Ariff B, Harvey C, et al. Comparative study of experienced vs non-experienced radiologists in assessing parametric CT images of the response of the prostate gland to radiotherapy. Br J Radiol. 2008;81:572–576
  21. Klein S, Staring M, Murphy K, Viergever M, Pluim J. Elastix: a toolbox for intensity-based medical image registration. IEEE Trans Med Imaging. 2010;29:196–205
  22. Smitsmans MHP, Wolthaus JWH, Artignan X, et al. Automatic localization of the prostate for on-line or off-line image-guided radiotherapy. Int J Radiat Oncol Biol Phys. 2004;60:623–635
  23. Tofts PS, Brix G, Buckley DL, et al. Estimating kinetic parameters from dynamic contrast-enhanced T(1)-weighted MRI of a diffusable tracer: standardized quantities and symbols. J Magn Reson Imaging. 1999;10:223–232
  24. Lawrence C, Zhou JL, Tits AL. User’s guide for CFSQP version 2.5: a C code for solving (large scale) constrained nonlinear (minimax) optimization problems, generating iterates satisfying all inequality constraints, Institute for Systems Research, University of Maryland, Technical Report TR-94-16r1, College Park, MD 20742, 1997.
  25. Noworolski SM, Vigneron DB, Chen AP, Kurhanewicz J. Dynamic contrast-enhanced MRI and MR diffusion imaging to distinguish between glandular and stromal prostatic tissues. Magn Reson Imaging. 2008;26:1071–1080
  26. Padhani AR, Gapinski CJ, Macvicar DA, et al. Dynamic contrast enhanced MRI of prostate cancer: correlation with morphology and tumour stage, histological grade and PSA. Clin Radiol. 2000;55:99–109
  27. Padhani AR, MacVicar AD, Gapinski CJ, et al. Effects of androgen deprivation on prostatic morphology and vascular permeability evaluated with MR imaging. Radiology. 2001;218:365–374
  28. Schabel CM, Parker DL. Uncertainty and bias in contrast concentration measurements using spoiled gradient echo pulse sequences. Phys Med Biol. 2008;53:2345–2373
  29. Zhang J, Rusinek H, Bokacheva L, Chen Q, Storey P, Lee V. Use of cardiac output to improve measurement of input function in quantitative dynamic contrast-enhanced MRI. J Magn Reson Imaging. 2009;30:656–665
  30. Parker GJ, Roberts C, Macdonald A, et al. Experimentally-derived functional form for a population-averaged high-temporal-resolution arterial input function for dynamic contrast-enhanced MRI. Magn Reson Med. 2006;56:993–1000
  31. Cheng HL. T1 measurement of flowing blood and arterial input function determination for quantitative 3D T1-weighted DCE-MRI. J Magn Reson Imaging. 2007;25:1073–1078
  32. Kershaw LE, Hutchinson CE, Buckley DL. Benign prostatic hyperplasia: evaluation of T1, T2, and microvascular characteristics with T1-weighted dynamic contrast-enhanced MRI. J Magn Reson Imaging. 2009;29:641–648
  33. Hanks GE, Hanlon AL, Schultheiss TE, et al. Dose escalation with 3D conformal treatment: five year outcomes, treatment optimization, and future directions. Int J Radiat Oncol Biol Phys. 1998;41:501–510
  34. Pickett B, Roach M, Verhey L, et al. The value of nonuniform margins for six-field conformal irradiation of localized prostate cancer. Int J Radiat Oncol Biol Phys. 1995;32:211–218
  35. Stroom JC, Storchi PR. Automatic calculation of three-dimensional margins around treatment volumes in radiotherapy planning. Phys Med Biol. 1997;42:745–755
  36. Pinkawa M, Attieh C, Piroth M, et al. Dose-escalation using intensity-modulated radiotherapy for prostate cancer – evaluation of the dose distribution with and without 18F-choline PET-CT detected simultaneous boost. Radiother Oncol. 2009;93:213–219
  37. Al-Mamgani A, van Putten WL, Heemsbergen WD, et al. Update of Dutch multicenter dose-escalation trial of radiotherapy for localized prostate cancer. Int J Radiat Oncol Biol Phys. 2008;72:980–988
  38. Haie-Meder C, Pötter R, Van Limbergen E, et al. Recommendations from Gynaecological (GYN) GEC-ESTRO Working Group (I): concepts and terms in 3D image based 3D treatment planning in cervix cancer brachytherapy with emphasis on MRI assessment of GTV and CTV. Radiother Oncol. 2005;74:235–245
  39. Pötter R, Haie-Meder C, van Limbergen E, et al. Recommendations from gynaecologycal (GYN) GEC ESTRO working group (II): concepts and terms in 3D image-based treatment planning in cervix cancer brchytherapy – 3D dose volume parameters and aspects of 3D image-based anatomy, radiation physics, radiobiology. Radiother Oncol. 2006;78:67–77
  40. Bentzen SM. Theragnostic imaging for radiation oncology: dose-painting by numbers. Lancet Oncol. 2005;6:112–117
  41. Vos PC, Hambrock T, Hulsbergen-van de Kaa CA, Futterer JJ, Barentsz JO, Huisman HJ. Computerized analysis of prostate lesions in the peripheral zone using dynamic contrast enhanced MRI. Med Phys. 2008;35:888–899

PII: S0167-8140(09)00681-1

doi: 10.1016/j.radonc.2009.12.023

Radiotherapy & Oncology
Volume 94, Issue 2 , Pages 168-172 , February 2010

Article Tools

* Image Usage & Resolution